Regulatory Q&A Forum

Ask questions, share knowledge, and get help from the regulatory community

Given the heightened responsibilities and joint liability assigned to the EU Authorised Representative (AR) under the Medical Device Regulation (EU) 2017/745 (MDR), how can a non-EU medical device man...

💬 1 👁️ 28 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

When planning for a 2026 submission of a novel in vitro diagnostic (IVD) device, particularly one that may not have a clear predicate or could fall into a classification requiring special controls, wh...

💬 1 👁️ 11 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

For an AI company based outside the EU that processes the personal data of EU residents, appointing a GDPR Article 27 representative is a mandatory step. However, given the complexity and scale of dat...

💬 1 👁️ 13 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

For foreign medical device establishments planning to enter the U.S. market, appointing a U.S. Agent is a mandatory step for FDA registration. Beyond simply fulfilling this requirement, what key facto...

💬 1 👁️ 19 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

With the introduction of the EU Carbon Border Adjustment Mechanism (CBAM), non-EU medical device manufacturers, who are already required to appoint an Authorized Representative (AR) under the Medical ...

💬 1 👁️ 9 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

Given the new compliance landscape created by the EU's Packaging and Packaging Waste Regulation (PPWR), how can non-EU manufacturers effectively evaluate the factors that influence the scope and cost ...

💬 1 👁️ 22 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

With the implementation of the EU's Packaging and Packaging Waste Regulation (PPWR), many non-EU economic operators will need to appoint an Authorized Representative (AR). While a primary concern is t...

💬 1 👁️ 28 👍 1
Asked: 3 weeks ago
Asked by Lo H. Khamis

With the implementation of the Modernization of Cosmetics Regulation Act (MoCRA), what are the specific, practical steps and strategic considerations for a foreign cosmetic product facility when appoi...

💬 1 👁️ 32 👍 1
Asked: 3 weeks ago
Asked by Lo H. Khamis

Given the new FDA requirements for cosmetic facility registration and product listing, foreign establishments must now appoint a U.S. Agent. While the cost of this service is a common question, the an...

💬 1 ✓ 👁️ 8 👍 1
Asked: 3 weeks ago
Asked by Lo H. Khamis

With the implementation of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) and the launch of the new electronic submission portal for cosmetic facility registration and product listing, ...

💬 1 👁️ 19 👍 1
Asked: 3 weeks ago
Asked by Lo H. Khamis

When a medical device manufacturer is preparing for compliance with multiple, distinct regulatory frameworks, selecting the right external expertise is critical. For companies subject to the EU Medica...

💬 1 👁️ 16 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

As manufacturers plan their regulatory budgets for 2026 and beyond, a common question arises regarding the cost of outsourcing the Person Responsible for Regulatory Compliance (PRRC) role as required ...

💬 1 👁️ 16 👍 1
Asked: 3 weeks ago
Asked by Lo H. Khamis

When medical device manufacturers, particularly small or micro-enterprises, plan to outsource the Person Responsible for Regulatory Compliance (PRRC) role under the EU MDR, how can they develop a comp...

💬 1 👁️ 15 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

For non-EU manufacturers of AI-enabled technologies, such as certain Software as a Medical Device (SaMD), how are the requirements for an EU AI Act 'Authorised Representative' expected to intersect wi...

💬 1 👁️ 25 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

For non-EU companies developing AI systems that process personal data from individuals in the European Union, navigating the complex regulatory landscape is a significant challenge. With the enforceme...

💬 1 ✓ 👁️ 29 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

For non-EU medical device manufacturers, appointing an EU Authorized Representative (AR) is a mandatory step for placing products on the European market under the Medical Device Regulation (EU) 2017/7...

💬 1 👁️ 16 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

When selecting an EU Authorized Representative (AR) under the Medical Device Regulation (MDR), what key strategic and operational criteria should a non-EU manufacturer evaluate to ensure a compliant a...

💬 1 👁️ 27 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

Given the significant updates to cosmetic regulations in the United States, how should foreign cosmetic product manufacturers and processors approach the mandatory requirement to designate a U.S. Agen...

💬 1 👁️ 14 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis

Given the recent FDA updates requiring foreign cosmetic facilities to register and appoint a United States agent, what key factors and service models should a company evaluate when selecting a U.S. Ag...

💬 1 👁️ 25 👍 0
Asked: 3 weeks ago
Asked by Lo H. Khamis

When a medical device manufacturer, particularly a small or micro-enterprise, decides to outsource the role of the Person Responsible for Regulatory Compliance (PRRC) under the EU Medical Device Regul...

💬 1 👁️ 27 👍 2
Asked: 3 weeks ago
Asked by Lo H. Khamis
Showing page 9 of 42 (830 total questions)